{"name":"Evolus, Inc.","slug":"evolus-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Botulinum purified neurotoxin, Type A","genericName":"Botulinum purified neurotoxin, Type A","slug":"botulinum-purified-neurotoxin-type-a","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Botulinum purified neurotoxin, Type A","genericName":"Botulinum purified neurotoxin, Type A","slug":"botulinum-purified-neurotoxin-type-a","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-01-15","type":"pipeline","source":"simplywall.st","summary":"Lacklustre Performance Is Driving Evolus, Inc.'s (NASDAQ:EOLS) 30% Price Drop - simplywall.st","headline":"Lacklustre Performance Is Driving Evolus, Inc.'s (NASDAQ:EOLS) 30% Price Drop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPVnI1NndTbElfc3JGczF1R0I3R2JibGYwNExldHFTMEU1R0Jycy0tX0cwMkFvSTE1NG9QUElqQjhaX09KOHJ4eGptTC0zclU2TmFOX3Y5ZzctTVZOcWlPUl9QUnk1QUFDRE5rRl83bTNUbFpRQjlnX1hPUFA1RnFOdDlxYlN0N1pPUVZVU1VWam9Fb2hWdl93cDVqZkEtQQ?oc=5","date":"2025-12-17","type":"pipeline","source":"seekingalpha.com","summary":"Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 (NASDAQ:EOLS) - seekingalpha.com","headline":"Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 (NASDAQ:EOLS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTE1QbkVaVW5GU3BwMXVIanFyQmx2VFVlQjVGT2F0andMMjM0QXRPa0NwS0d5alhIemFPZ29JelMtRTZmQlg0ZkVMdHNPQ2NwMnB5YVhFY3hHcFM?oc=5","date":"2025-09-16","type":"pipeline","source":"webull.com","summary":"Evolus, Inc. (NASDAQ:EOLS): When Will It Breakeven? - webull.com","headline":"Evolus, Inc. (NASDAQ:EOLS): When Will It Breakeven?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-16","type":"pipeline","source":"simplywall.st","summary":"Evolus, Inc. (NASDAQ:EOLS): When Will It Breakeven? - simplywall.st","headline":"Evolus, Inc. (NASDAQ:EOLS): When Will It Breakeven?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-10","type":"pipeline","source":"simplywall.st","summary":"Analysts Just Slashed Their Evolus, Inc. (NASDAQ:EOLS) EPS Numbers - simplywall.st","headline":"Analysts Just Slashed Their Evolus, Inc. (NASDAQ:EOLS) EPS Numbers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPOWNUd01ZRUdOS0pfRlNaV3ZwVmRzYkZfU1VLVmxucW9uaTRqdGtHLWo2Tmt3SzlpUG5rdWpfTE9WR09KbWo1T0l4MmVCdVNqbV9tSFhOVkRESl9aT1Vmc2ZwSjJQbFo1ZWpzaTNuVHdyVXZOSHc2WEpXb09SXzhhNW1WZU95akk2eGpsV2xacGc?oc=5","date":"2025-07-21","type":"earnings","source":"seekingalpha.com","summary":"Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings (NASDAQ:EOLS) - seekingalpha.com","headline":"Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings (NASDAQ:EOLS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOVTNNRjByb3BWeHBuM1NWeDExUHZ6LWJmZWhEZnkydGdDOG5OdnRFcVY3c1RuMldVWGdfTG5kNlI1Tm1mQllIQU1jMlZTaWVqdzQtUzZ6ZktGQV9FTURCWDNvQUJjc1I1TnJrUUlWX0VRZ0hlUVdLbWFiLVNnTTlGWFJTcTFxVC1ERS1CczVOMFBXTlli?oc=5","date":"2025-07-09","type":"pipeline","source":"Yahoo Finance","summary":"Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France - Yahoo Finance","headline":"Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNSTB5dGVLTURmQm5mTkFpTGtkb1FZdWtRWUV6ZXdBZzZ0cWxtM3VsRXN5S0hvWUd1dTE1aU1tOW0xS2xkeUpBX0dYOFQ2Q3d6T3gyenBHa3FtdVdySE9ib085VFdkX0FpaXdGemtOT1R5c2VUc3kxV3lxY1ZSV2hfeng0Yw?oc=5","date":"2025-06-20","type":"earnings","source":"Yahoo Finance","summary":"When Can We Expect A Profit From Evolus, Inc. (NASDAQ:EOLS)? - Yahoo Finance","headline":"When Can We Expect A Profit From Evolus, Inc. (NASDAQ:EOLS)?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1BVXdmQVluZHFUT1duNGxfLW5nVXhfcndscVB2Zk92a0JHVHJnZzZQNWxLT0gzaXE5clZMRTY5RkE5aGt6Y3ZLakJaMENqWDh3UTlmc2ZQZnQtYXBTOVZjN1B1c1Jfb2NxZ2hocGJ1dWVrQQ?oc=5","date":"2025-05-13","type":"pipeline","source":"finviz.com","summary":"Evolus, Inc. (EOLS): A Bull Case Theory - finviz.com","headline":"Evolus, Inc. (EOLS): A Bull Case Theory","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5NODVPYi1vVUtTRVdWYktWOHFXLUtXcGdPbi1lT2lVSmpfdHpQRmZFV1RNeXNyOUxzN2JOSHFHb2h5dVFSUEMwLUliZGxHUldYNElXcC1wNDFsZldmQmZVNzRjVHlQZmlQRXhKUUNB0gFyQVVfeXFMTzd4dk53N0tJTXRhNDNROHhKQWNfejEzQkF5cEV2WXdMSUZUcFZTam4yTDVQcFhlQ2NtblFTbk80c3R0TVNxVElpb0FGRVNHbXNKbG9jMVlfRFNHWWJuNzZDeG1iazJxZFNDekZJMXF4RGpR?oc=5","date":"2024-10-04","type":"earnings","source":"koreabiomed.com","summary":"Medytox to secure ₩77 billion profit from Evolus stock sale - koreabiomed.com","headline":"Medytox to secure ₩77 billion profit from Evolus stock sale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5kTUpKU3UwRWl2elNldDJnbi1tQm9lS1hWV3ZSbnJBNjdyX2JuMGNKeWpHSTBHV1VCY0xqNkhSSUozcjhidUs1QkUwTGZhdDFVaGhKNVRn?oc=5","date":"2024-06-12","type":"pipeline","source":"The Korea Herald","summary":"Evolus CEO vows to boost US sales of Daewoong's botulinum toxin - The Korea Herald","headline":"Evolus CEO vows to boost US sales of Daewoong's botulinum toxin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNSXEyTzl3N25lRzRvMHNXTXh5VG5yUmQ3RFh6bmRzbjdUbi1BZHY2OHI5ZEJ4bFBZU3RzUjc4ZVRyMXBuLWpUNlJYUTZ0XzAycXFGLTI4aEpGc3N5UGNYZkxVQ1VYdE5iNHJrUlU1aHVmdVE0enluU0lXMFNUS3lDNWFSVV9UWFBwbGhpZzJTYS1JQmF4bEZlNnR0SFlnQ1ZETXhoWWpacVNpQQ?oc=5","date":"2023-02-10","type":"pipeline","source":"businesswire.com","summary":"Evolus Not Affected by Recent Korean Court Ruling - businesswire.com","headline":"Evolus Not Affected by Recent Korean Court Ruling","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}